Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Mol Plant Pathol ; 24(10): 1330-1346, 2023 10.
Artículo en Inglés | MEDLINE | ID: mdl-37522519

RESUMEN

The tea plant (Camellia sinensis) is susceptible to anthracnose disease that causes considerable crop loss and affects the yield and quality of tea. Multiple Colletotrichum spp. are the causative agents of this disease, which spreads quickly in warm and humid climates. During plant-pathogen interactions, resistant cultivars defend themselves against the hemibiotrophic pathogen by activating defence signalling pathways, whereas the pathogen suppresses plant defences in susceptible varieties. Various fungicides have been used to control this disease on susceptible plants, but these fungicide residues are dangerous to human health and cause fungicide resistance in pathogens. The problem-solving approaches to date are the development of resistant cultivars and ecofriendly biocontrol strategies to achieve sustainable tea cultivation and production. Understanding the infection stages of Colletotrichum, tea plant resistance mechanisms, and induced plant defence against Colletotrichum is essential to support sustainable disease management practices in the field. This review therefore summarizes the current knowledge of the identified causative agent of tea plant anthracnose, the infection strategies and pathogenicity of C. gloeosporioides, anthracnose disease resistance mechanisms, and the caffeine-induced defence response against Colletotrichum infection. The information reported in this review will advance our understanding of host-pathogen interactions and eventually help us to develop new disease control strategies.


Asunto(s)
Camellia sinensis , Colletotrichum , Fungicidas Industriales , Humanos , Camellia sinensis/metabolismo , Enfermedades de las Plantas , Resistencia a la Enfermedad , Té/metabolismo
2.
RNA Biol ; 17(10): 1365-1382, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32478595

RESUMEN

MicroRNAs play a central role in responses to biotic stressors through their interactions with their target mRNAs. Tea plant (Camellia sinensis L.), an important beverage crop, is vulnerable to tea geometrid and anthracnose disease that causes considerable crop loss and tea production worldwide. Sustainable production of tea in the current scenario to biotic factors is major challenges. To overcome the problem of biotic stresses, high-throughput sequencing (HTS) with bioinformatics analyses has been used as an effective approach for the identification of stress-responsive miRNAs and their regulatory functions in tea plant. These stress-responsive miRNAs can be utilized for miRNA-mediated gene silencing to enhance stress tolerance in tea plant. Therefore, this review summarizes the current understanding of miRNAs regulatory functions in tea plant responding to Ectropis oblique and Colletotrichum gloeosporioides attacks for future miRNA research. Also, it highlights the utilization of miRNA-mediated gene silencing strategies for developing biotic stress-tolerant tea plant.


Asunto(s)
Camellia sinensis/genética , MicroARNs/genética , Interferencia de ARN , Estrés Fisiológico , Resistencia a la Enfermedad/genética , Perfilación de la Expresión Génica , Regulación de la Expresión Génica de las Plantas , Silenciador del Gen , Secuenciación de Nucleótidos de Alto Rendimiento , Interacciones Huésped-Patógeno/genética , Enfermedades de las Plantas/genética , Enfermedades de las Plantas/microbiología , ARN Mensajero
3.
Hum Genomics ; 12(1): 27, 2018 05 21.
Artículo en Inglés | MEDLINE | ID: mdl-29784039

RESUMEN

BACKGROUND: Mutations in keratin proteins have been vastly associated with a wide array of genodermatoses; however, mutations of keratins in psoriasis have not been fully investigated. The main aim of the current research was to identify the mutation in K14, K10, K16, and K17 genes in two stages of psoriasis patients. METHODS: Ninety-six psoriatic skin biopsies were collected. mRNA transcript of K14, K10, K16, and K17 was prepared, amplified, and sequenced. Sanger sequences of all keratins were further validated for mutational analysis using Mutation Surveyor and Alamut Visual. Then, in silico analysis of protein stability and protein and gene expression of all keratins was performed and validated. RESULTS: Out of 44 mutations, about 75% of keratins are highly pathogenic and deleterious. Remaining 25% mutations are less pathogenic and tolerated in nature. In these 33 deleterious mutations were immensely found to decrease keratin protein stability. We also found a correlation between keratin and Psoriasis Area and Severity Index score which added that alteration in keratin gene in skin causes severity of psoriasis. CONCLUSIONS: We strongly concluded that acanthosis and abnormal terminal differentiation was mainly due to the mutation in epidermal keratins. In turn, disease severity and relapsing of psoriasis are mainly due to the mutation of hyperproliferative keratins. These novel keratin mutations in psoriatic epidermis might be one of the causative factors for psoriasis.


Asunto(s)
Queratinas Tipo I/genética , Queratinas/genética , Mutación/genética , Psoriasis/genética , Acantosis Nigricans/genética , Acantosis Nigricans/fisiopatología , Adolescente , Adulto , Anciano , Biopsia , Diferenciación Celular , Proliferación Celular/genética , Análisis Mutacional de ADN , Epidermis/metabolismo , Epidermis/fisiopatología , Femenino , Humanos , Queratinas/clasificación , Masculino , Persona de Mediana Edad , Estabilidad Proteica , Psoriasis/patología , Índice de Severidad de la Enfermedad , Piel/metabolismo , Piel/patología , Adulto Joven
4.
Ann Rheum Dis ; 77(3): 417, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29233832

RESUMEN

OBJECTIVES: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of considerable genetic predisposition. Genome-wide association studies have identified tens of common variants for SLE. However, the majority of them reside in non-coding sequences. The contributions of coding variants have not yet been systematically evaluated. METHODS: We performed a large-scale exome-wide study in 5004 SLE cases and 8179 healthy controls in a Han Chinese population using a custom exome array, and then genotyped 32 variants with suggestive evidence in an independent cohort of 13 246 samples. We further explored the regulatory effect of one novel non-coding single nucleotide polymorphism (SNP) in ex vivo experiments. RESULTS: We discovered four novel SLE gene regions (LCT, TPCN2, AHNAK2 and TNFRSF13B) encompassing three novel missense variants (XP_016859577.1:p.Asn1639Ser, XP_016859577.1:p.Val219Phe and XP_005267356.1:p.Thr4664Ala) and two non-coding variants (rs10750836 and rs4792801) with genome-wide significance (pmeta <5.00×10-8). These variants are enriched in several chromatin states of primary B cells. The novel intergenic variant rs10750836 exhibited an expression quantitative trait locus effect on the TPCN2 gene in immune cells. Clones containing this novel SNP exhibited gene promoter activity for TPCN2 (P=1.38×10-3) whose expression level was reduced significantly in patients with SLE (P<2.53×10-2) and was suggested to be further modulated by rs10750836 in CD19+ B cells (P=7.57×10-5) in ex vivo experiments. CONCLUSIONS: This study identified three novel coding variants and four new susceptibility gene regions for SLE. The results provide insights into the biological mechanism of SLE.


Asunto(s)
Pueblo Asiatico/genética , Lupus Eritematoso Sistémico/genética , Adulto , Exoma , Femenino , Predisposición Genética a la Enfermedad , Estudio de Asociación del Genoma Completo , Genotipo , Humanos , Lupus Eritematoso Sistémico/etnología , Masculino , Persona de Mediana Edad , Mutación , Polimorfismo de Nucleótido Simple , Sitios de Carácter Cuantitativo , Reacción en Cadena en Tiempo Real de la Polimerasa
5.
Clin Exp Med ; 17(3): 371-381, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27435483

RESUMEN

Psoriasis is a chronic inflammatory skin disease characterized by hyper proliferation of keratinocytes. Recent data show that the epidermis thickening in psoriasis may be related to imbalance of homeostasis caused by abnormal apoptotic process. Maintenance of keratinocyte apoptotic process is very important in psoriasis. Methotrexate (MTX) has been used for many years to restore the normal skin in psoriasis condition. However, the exact mechanism of MTX in psoriasis condition is poorly understood. The aim of this study was to examine the role of MTX on keratinocyte apoptosis pathway in psoriasis patients. A total of 58 psoriasis vulgaris patients were recruited for this study. Nonlesional skin biopsies served as control. Skin biopsies of psoriatic patients were collected and analyzed for cytosolic, mitochondria and total cytochrome c by ELISA. Expression of caspase-9, NFκBp65, pAkt1 by western blot, real-time PCR and immunohistochemical analysis of c-FLIP protein was analyzed in nonlesional and lesional skin biopsies before (day 0) and after (at the end of 6 and 12 weeks) MTX treatment. After MTX treatment, a significant increase in cytochrome c was observed when compared with before MTX treatment in psoriasis patients (p < 0.001). Protein and gene expression of cleaved caspase-9 were significantly increased after MTX treatment, whereas the expression of Bcl-xL, c-FLIP, NFκBp65, pAkt1 significantly downregulated after MTX treatment. In conclusion, these results showed that intrinsic apoptotic pathway induced by MTX eventually adds the beneficial therapeutic role of MTX in psoriasis by controlling the acanthosis.


Asunto(s)
Apoptosis/efectos de los fármacos , Fármacos Dermatológicos/administración & dosificación , Queratinocitos/efectos de los fármacos , Metotrexato/administración & dosificación , Psoriasis/tratamiento farmacológico , Piel/efectos de los fármacos , Piel/patología , Adolescente , Adulto , Anciano , Biopsia , Ensayo de Inmunoadsorción Enzimática , Femenino , Perfilación de la Expresión Génica , Humanos , Queratinocitos/química , Queratinocitos/fisiología , Masculino , Persona de Mediana Edad , Reacción en Cadena en Tiempo Real de la Polimerasa , Adulto Joven
6.
Clin Chim Acta ; 453: 164-9, 2016 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-26707913

RESUMEN

BACKGROUND: Caspase-1 induces the proinflammatory cytokines which appears to be a promising target in Th1-type inflammatory diseases, like psoriasis. We determined the effect of MTX on caspase-1, TNF-α and IL-18 in psoriasis patients. METHODS: We recruited 45 control subjects and 58 psoriasis patients for this study. The patients were treated with 7.5mg of MTX per week for 12weeks. Folic acid was given at 5mg once daily except on the day of MTX for 12weeks. Blood samples and lesional skin biopsy were taken. Histological examination has been done. IL-18 and TNF-α levels were analyzed by using ELISA. Caspase-1 expression was analyzed by western blot and Real Time PCR. RESULTS: Histological examinations showed MTX decreased acanthosis in psoriasis skin. Plasma IL-18 level and serum TNF-α were increased in psoriasis and deduced significantly (P<0.001) after MTX treatment. Protein and mRNA expression of caspase-1 in skin biopsy were higher in psoriasis and reduced significantly (P<0.001) after MTX treatment. CONCLUSION: Decreasing inflammatory caspase and proinflammatory cytokines by MTX, inhibits the Th1 response in psoriasis. This shows the therapeutic effect of MTX in controlling the immunopathogenesis of psoriasis.


Asunto(s)
Caspasa 1/metabolismo , Interleucina-18/sangre , Metotrexato/farmacología , Psoriasis/tratamiento farmacológico , Células TH1/efectos de los fármacos , Células TH1/metabolismo , Factor de Necrosis Tumoral alfa/sangre , Adolescente , Adulto , Anciano , Estudios de Casos y Controles , Caspasa 1/genética , Femenino , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Humanos , Masculino , Metotrexato/uso terapéutico , Persona de Mediana Edad , Psoriasis/inmunología , Psoriasis/metabolismo , Psoriasis/patología , Piel/efectos de los fármacos , Piel/inmunología , Piel/patología , Adulto Joven
7.
Clin Chim Acta ; 451(Pt B): 329-37, 2015 Dec 07.
Artículo en Inglés | MEDLINE | ID: mdl-26499845

RESUMEN

BACKGROUND: In psoriatic skin, epidermal keratinocytes undergo deregulated inflammatory response that leads to prolonged expression of inflammatory mediators as well as abnormal keratins. Methotrexate (MTX) is an immunosuppressive agent used as a standard drug to treat severe psoriasis. The aim of the study is to find the pharmacological effect of MTX on abnormal keratin and deregulated inflammatory mediators. METHODS: Fifty-eight psoriasis vulgaris patients were recruited for this study. Skin biopsies of psoriatic patients were collected and analyzed for activation signal such as TNF-α and IFN-γ and deactivation signal such as TGF-ß1. Also, protein and gene expression of normal keratins K14 and K10 and abnormal keratins K16 and K17 were analyzed in skin biopsies before (day 0) and after (at the end of 6 and 12 weeks) MTX treatment. RESULTS: Results show a significant decrease in tissue TNF-α and IFN-γ and increase in TGF-ß1 after MTX treatment when compared with before MTX treatment in psoriasis patients (p<0.001). Protein and gene expression of K14, K16 and K17 decreased after MTX treatment, whereas the expression of differentiation marker K10 increased after MTX treatment. CONCLUSION: MTX resolves deregulated inflammatory markers and maintains normal keratin phenotype on hyperproliferating KC, thereby controlling acanthosis in psoriasis patients.


Asunto(s)
Mediadores de Inflamación/metabolismo , Queratinocitos/efectos de los fármacos , Queratinocitos/metabolismo , Queratinas/metabolismo , Metotrexato/farmacología , Psoriasis/tratamiento farmacológico , Adolescente , Adulto , Anciano , Ciclo Celular/efectos de los fármacos , Regulación hacia Abajo/efectos de los fármacos , Femenino , Humanos , Queratinocitos/citología , Queratinocitos/patología , Masculino , Metotrexato/uso terapéutico , Persona de Mediana Edad , Psoriasis/metabolismo , Psoriasis/patología , Adulto Joven
8.
Int J Dermatol ; 54(3): 302-6, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25267471

RESUMEN

BACKGROUND: Propylthiouracil (PTU), an anti-thyroid thioureylene, has been shown to be effective in chronic plaque psoriasis. Involucrin is a precursor protein that is upregulated in psoriasis. OBJECTIVES: This study evaluated the expression of involucrin in the epidermis of skin in psoriatic plaques before and after treatment with PTU. METHODS: This was an open-label, prospective study in which 25 psoriasis patients underwent skin biopsies prior to treatment with oral PTU 100 mg three times per day for 12 weeks. Patients were assessed at 2, 6, and 12 weeks. Skin biopsies were repeated at the same sites at 12 weeks. Pre- and post-treatment specimens were subjected to immunohistochemical staining and real-time polymerase chain reaction for involucrin. RESULTS: Mean ± standard deviation (SD) scores on the Psoriasis Area and Severity Index reduced significantly from 17.86 ± 9.9 at baseline to 4.63 ± 4.1 at week 12 (P < 0.001). Histomorphometric analysis revealed marked decreases in numbers of positively stained cells and intensity of staining. Staining became localized to the upper granular layers after therapy. Immunohistochemical scoring for involucrin reduced from a mean ± SD of 9.00 ± 0.67 at baseline to 3.90 ± 0.88 at week 12 (P < 0.0001). CONCLUSIONS: In psoriasis, there is increased expression of involucrin, which leads to abnormal keratinocyte differentiation and hence to the formation of psoriatic plaques. The therapeutic effect of PTU in psoriasis may be attributable to the downregulation of involucrin. Larger trials should further elucidate the mechanism and therapeutic potential of PTU in psoriasis.


Asunto(s)
Antitiroideos/uso terapéutico , Propiltiouracilo/uso terapéutico , Precursores de Proteínas/análisis , Precursores de Proteínas/genética , Psoriasis/tratamiento farmacológico , Psoriasis/metabolismo , Adulto , Anciano , Regulación hacia Abajo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , ARN/análisis , Índice de Severidad de la Enfermedad , Adulto Joven
9.
Clin Exp Med ; 14(4): 431-7, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23949337

RESUMEN

Methotrexate (MTX), a cytotoxic chemotherapeutic agent, is considered an effective drug in the treatment of psoriasis. The aim of this study was to find out whether the effect of MTX treatment in psoriasis is due to oxidative stress-induced apoptosis. Psoriasis vulgaris patients (58 in number) were recruited for this study. Healthy volunteers (45 in number) served as control. Samples of psoriatic patients were collected and analyzed for total reactive oxygen species (ROS), malondialdehyde (MDA) levels, nitrite, nitrate levels and the activities of antioxidants like superoxide dismutase (SOD), catalase (CAT) and total antioxidant status (TAS) and also the protein expression of caspase-3, before (Day 0) and after (at the end of 6 and 12 weeks) MTX treatment. Our results show a significant increase in tissue ROS and plasma MDA after MTX treatment when compared with before MTX treatment in psoriasis patients (p < 0.001). The levels of serum nitrite and nitrate were decreased significantly after MTX treatment (p < 0.001). The activities of plasma SOD, TAS and serum CAT levels were decreased, but not significantly after 12 weeks of treatment. The expression of caspase-3 was increased after MTX treatment. In conclusion, MTX induce apoptosis through oxidative stress by reducing NO and increasing caspase-3 levels. MTX-induced apoptosis may account for the beneficial effect of MTX treatment in psoriasis patients, which is characterized by acanthosis.


Asunto(s)
Apoptosis/efectos de los fármacos , Fármacos Dermatológicos/uso terapéutico , Metotrexato/uso terapéutico , Estrés Oxidativo/efectos de los fármacos , Psoriasis/tratamiento farmacológico , Psoriasis/patología , Adolescente , Adulto , Anciano , Antioxidantes/análisis , Femenino , Humanos , Masculino , Malondialdehído/sangre , Persona de Mediana Edad , Nitratos/sangre , Nitritos/sangre , Especies Reactivas de Oxígeno/análisis , Adulto Joven
10.
Clin Chim Acta ; 413(19-20): 1652-6, 2012 Oct 09.
Artículo en Inglés | MEDLINE | ID: mdl-22609260

RESUMEN

BACKGROUND: Psoriasis is a chronic autoimmune hyperproliferative skin disease. In psoriasis, the cutaneous and systemic overexpression of various proinflammatory cytokines, such as interleukin-6 (IL-6) has been demonstrated. Methotrexate (MTX) has been used in the treatment of psoriasis. The aim of this study is to assess the effect of MTX on serum IL-6 levels and also to find the association between PASI score and IL-6 levels in psoriatic patients during MTX therapy. METHODS: We recruited 20 control subjects and 22 Psoriasis vulgaris patients for this study. The patients were treated with 7.5mg of methotrexate per week for 12 weeks. Folic acid was given at 5mg once daily except on the day of MTX for 12 weeks. There were 2 dropouts, because of increased liver enzyme levels. Blood samples were collected at three intervals (i.e., Day 0, 6 weeks, 12 weeks) from psoriatic patients and only once from control subjects. PASI score, biochemical and hematological parameters were assessed. Serum IL-6 level was analyzed by using ELISA. RESULTS: Biochemical and hematological parameters showed no significant changes. Serum IL-6 level and PASI score declined significantly (p<0.001) from Day 0 to 12 weeks of MTX treatment and also showed positive correlation before (r=0.992; p<0.000) and after (r=0.987; p<0.000) treatment with MTX. Out of 4 clinical indices of PASI, only 2 indices namely Infiltration (I) and Desquamation (D) showed positive correlation with IL-6 before and after MTX treatment. CONCLUSION: The treatment response with MTX in psoriatic patients can be seen both at clinical and molecular levels.


Asunto(s)
Fármacos Dermatológicos/administración & dosificación , Interleucina-6/sangre , Metotrexato/administración & dosificación , Psoriasis/sangre , Adulto , Anciano , Esquema de Medicación , Ensayo de Inmunoadsorción Enzimática , Femenino , Ácido Fólico/administración & dosificación , Humanos , Interleucina-6/inmunología , Masculino , Persona de Mediana Edad , Psoriasis/tratamiento farmacológico , Psoriasis/inmunología , Proyectos de Investigación , Resultado del Tratamiento
11.
Int J Yoga ; 5(1): 21-7, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22346062

RESUMEN

BACKGROUND: Yoga is a science practiced in India over thousands of years. It produces constituent physiological changes and has sound scientific basis. AIM: Since exam stress modifies lipid profile and hematological parameters, we conducted an investigation on the effect of sudarshan kriya (SK and P) program on these parameters. MATERIALS AND METHODS: Blood samples of 43 engineering students were collected at four intervals namely baseline (BL), exam stress (ES), three and six weeks practice of SK and P during exam stress. Lipid profile and hematological parameters were measured at all four intervals. RESULTS: ES elevated total cholesterol (TC), triglycerides (TGL) and very low density lipoprotein (VLDL) levels. Hematological parameters affected by ES included neutrophil, lymphocytes, platelet count, packed cell volume (PCV) and mean cell volume (MCV). Three and six weeks practice of SK and P reduced the elevated lipid profile, hematological parameters and improved lymphocyte levels. CONCLUSION: Our study indicates that SK and P practice has the potential to overcome ES by improving lipid profile and hematological parameters.

12.
Clin Biochem ; 44(14-15): 1209-13, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21820424

RESUMEN

OBJECTIVE: Propylthiouracil (PTU) is an effective drug for psoriasis treatment. Prolactin (PRL) is increased during psoriasis which has hyperproliferative effect on keratinocytes. Hence, the objective is to find the effect of PTU on PRL level in psoriatic patients. DESIGN AND METHODS: 25 psoriatic patients and 10 control subjects were involved in the study. Serum PRL, hematological and biochemical parameters, thyroid profile and histopathological examination were performed. RESULTS: PTU treatment for 6 weeks and 12 weeks cleared psoriatic lesions indicated by decreased PASI score (p<0.001). Patients before treatment showed significantly increased PRL levels (male p<0.01, female p<0.001) when compared to controls, which was found to decrease significantly (male p<0.01, female p<0.001) after 12 weeks. Hematological and biochemical parameters showed no significant change. Histopathology showed reduced thickening of the epidermis and acanthosis after PTU treatment. CONCLUSION: Since PRL is a growth hormone involved in hyperproliferation of keratinocytes, this study reveals the antiproliferative effect of PTU. Furthermore, no major side effects were observed following PTU treatment.


Asunto(s)
Prolactina/sangre , Propiltiouracilo/uso terapéutico , Psoriasis/tratamiento farmacológico , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Psoriasis/sangre , Psoriasis/patología , Resultado del Tratamiento
13.
Indian J Med Sci ; 65(8): 331-6, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23442529

RESUMEN

BACKGROUND: Psoriasis greatly impacts the quality of life (QOL) of patients including several dermatological conditions that are listed in the Dermatology Life Quality Index (DLQI). Decrease in psoriatic lesion as measured by Psoriasis Area Severity Index (PASI) score is associated with improvement in QOL. Propylthiouracil (PTU) was found to be clinically efficient in clearing psoriatic lesions. Our objective is to find the extent of improvement in QOL in psoriatic patients treated with PTU. MATERIALS AND METHODS: Twenty-three psoriatic patients who were taking 300 mg PTU/day were involved in the study. Clinical improvement was assessed by PASI score and QOL was assessed by DLQI questionnaire at baseline, 6 th and 12 th week of PTU treatment. RESULTS: Psoriatic patients before treatment showed significantly increased DLQI score when compared with 6 and 12 weeks of PTU treatment which was found to be decreased significantly (P < 0.001) after PTU treatment. There was a positive correlation between DLQI and PASI score at all three intervals of treatment period at P < 0.001 (r = 0.793, r = 0.834, r = 0.801), respectively. CONCLUSION: Since PTU was found to improve the QOL of psoriasis patients, this study adds an advantage of using it as treatment option in psoriasis.


Asunto(s)
Satisfacción del Paciente , Propiltiouracilo/uso terapéutico , Psoriasis/tratamiento farmacológico , Psoriasis/psicología , Calidad de Vida , Adulto , Antimetabolitos/uso terapéutico , Femenino , Humanos , Masculino , Encuestas y Cuestionarios
14.
Indian J Med Sci ; 64(11): 501-7, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23051942

RESUMEN

INTRODUCTION: Medical education is perceived as stressful. As excessive stress hampers students' performance, stress management is required for medical students. This study was aimed to assess the effect of Mind Sound Technology (MST), an intelligence enhancing program, on psychological well-being of medical undergraduates during exam stress. MATERIALS AND METHODS: Forty-two medical students were recruited and Dukes Health Profile scoring was done at baseline and during Exam Stress (ES). After pre-intervention measurements, the students were randomized into two groups: non-practitioners and MST practitioners. Post-intervention measurement was done at the end of 6 weeks when the students had examination. RESULTS: Students showed a significant increase (P < 0.001) in negative health scores like perceived health scores, anxiety, and depression and a significant decrease (P < 0.001) in positive health scores like Self-Esteem, Mental Health Score, Social Health Score, and General Health Score during exam when compared with baseline. MST practice increased positive health scores (P < 0.001) and decreased perceived health score (P < 0.01), anxiety, depression, and anxiety-depression scores significantly (P < 0.001) when compared with ES score. Non practitioners did not show any significant change in any of the scores when compared with ES score. Six weeks of MST practice by medical students have improved the academic scores (P < 0.05) when compared with their non-practitioner counterpart. CONCLUSION: Thus, practice of MST has helped in coping up the stress that occurs during examination and improved academic performance in medical undergraduates.


Asunto(s)
Control de la Conducta , Tecnología Educacional/métodos , Pruebas Psicológicas , Estrés Psicológico/prevención & control , Estudiantes de Medicina/psicología , Materiales de Enseñanza , Adaptación Psicológica , Control de la Conducta/métodos , Control de la Conducta/psicología , Educación de Pregrado en Medicina , Femenino , Humanos , Masculino , Salud Mental/clasificación , Psicología Educacional/métodos , Estrés Psicológico/etiología , Estrés Psicológico/psicología , Habilidades para Tomar Exámenes/métodos , Habilidades para Tomar Exámenes/psicología , Resultado del Tratamiento , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...